Approval For Expansion Of Subzone 99D, AstraZeneca Pharmaceuticals LP Plant, (Pharmaceutical Products), Newark and Wilmington, Delaware, 34303-34304 [E6-9304]
Download as PDF
Federal Register / Vol. 71, No. 114 / Wednesday, June 14, 2006 / Notices
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Order No. 1454]
Designation of New Grantee For
Foreign–Trade Zone 174, Tucson,
Arizona, Resolution And Order
Pursuant to its authority under the
Foreign–Trade Zones Act of June 18,
1934, as amended (19 U.S.C. 81a–81u),
and the Foreign–Trade Zones Board
Regulations (15 CFR Part 400), the
Foreign–Trade Zones Board (the Board)
adopts the following Order:
The Foreign–Trade Zones (FTZ)
Board (the Board) has considered
the application (filed 9/23/2005)
submitted by the City of Tucson,
grantee of FTZ 174, Tucson,
Arizona, requesting reissuance of
the grant of authority for said zone
to the Tucson Regional Economic
Opportunities, Inc., a non–profit
corporation, which has accepted
such reissuance subject to approval
by the FTZ Board. Upon review, the
Board finds that the requirements of
the FTZ Act and the Board’s
regulations are satisfied, and that
the proposal is in the public
interest, approves the request and
recognizes the Tucson Regional
Economic Opportunities, Inc. as the
new grantee of Foreign–Trade Zone
174.
The approval is subject to the FTZ Act
and the FTZ Board’s regulations,
including Section 400.28.
Signed at Washington, DC, this 31st
day of May 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import
Administration.
Alternate Chairman Foreign–Trade Zones
Board.
Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–9307 Filed 6–13–06; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
rwilkins on PROD1PC63 with NOTICES
[Docket 21–2006]
Foreign–Trade Zone 99 – Wilmington,
Delaware, Expansion of Manufacturing
Authority—Subzone 99E, The Premcor
Refining Group Inc., Delaware City,
Delaware
An application has been submitted to
the Foreign–Trade Zones Board (the
Board) by the Delaware Economic
VerDate Aug<31>2005
20:36 Jun 13, 2006
Jkt 208001
Development Office, grantee of FTZ 99,
requesting authority on behalf of The
Premcor Refining Group Inc. (Premcor),
to expand the scope of manufacturing
activity conducted under zone
procedures within Subzone 99E at the
Premcor oil refinery complex in
Delaware City, Delaware. The
application was submitted pursuant to
the provisions of the Foreign–Trade
Zones Act, as amended (19 U.S.C. 81a–
81u), and the regulations of the Board
(15 CFR part 400). It was formally filed
on May 31, 2006.
Subzone 99E (152,000 BPD capacity
2,450 employees) was approved by the
Board in 1996 for the manufacture of
fuel products and certain petrochemical
feedstocks and refinery by–products
(Board Order 831, 61 FR 33490, 6/27/96,
as amended by Board Order 1116, 65 FR
52696, 8/30/00).
The refinery complex (1,800 acres)
consists of a main refinery/
petrochemical plant, storage tanks and a
marine terminal, located at 2000
Wrangle Hill Road, Delaware City in
Newcastle County, Delaware, some 35
miles south of Philadelphia.
The expansion request involves an
expansion of the crude throughput at
the refinery due to increased
efficiencies, improvements in
equipment reliability and longer cycles
between turnarounds to increase the
overall crude distillation capacity of the
refinery to 180,000 BPD. No additional
feedstocks or products have been
requested.
Zone procedures would exempt the
increased production from customs duty
payments on the foreign products used
in its exports. On domestic sales, the
company would be able to choose the
customs duty rates for certain
petrochemical feedstocks (duty–free) by
admitting foreign crude oil in non–
privileged foreign status. The
application indicates that the savings
from zone procedures help improve the
refinery’s international competitiveness.
In accordance with the Board’s
regulations, a member of the FTZ staff
has been appointed examiner to
investigate the application and report to
the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at the
address below. The closing period for
their receipt is August 14, 2006.
Rebuttal comments in response to
material submitted during the foregoing
period may be submitted during the
subsequent 15-day period to August 28,
2006.
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
34303
A copy of the application and
accompanying exhibits will be available
for public inspection at each of the
following locations:
U.S. Department of Commerce Export
Assistance Center, The Curtis Center,
Suite 580 West, Independence Square
West, Philadelphia, PA 19106.
Office of the Executive Secretary,
Foreign–Trade Zones Board, U.S.
Department of Commerce, Room 1115,
1401 Constitution Ave. NW.,
Washington, DC 20230.
Dated: May 31, 2006.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–9288 Filed 6–13–06; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Order No. 1455]
Approval For Expansion Of Subzone
99D, AstraZeneca Pharmaceuticals LP
Plant, (Pharmaceutical Products),
Newark and Wilmington, Delaware
Pursuant to its authority under the
Foreign–Trade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the Foreign–
Trade Zones Board (the Board) adopts the
following Order:
Whereas, the Delaware Economic
Development Office, grantee of FTZ 99,
has requested authority on behalf of
AstraZeneca Pharmaceuticals LP
(AstraZeneca), to expand the subzone
boundaries and to expand the scope of
manufacturing authority under zone
procedures in terms of both products
and capacity at Subzone 99D at the
AstraZeneca pharmaceuticals
manufacturing plant in Newark,
Delaware (FTZ Docket 22–2005, filed 5/
17/2005); and,
Whereas, notice inviting public
comment has been given in the Federal
Register (70 FR 30079, 5/25/05);
Whereas, the Board adopts the
findings and recommendation of the
examiner’s report, and finds that the
requirements of the FTZ Act and
Board’s regulations are satisfied, and
that approval of the application is in the
public interest;
Now, therefore, the Board hereby
approves the expansion of the subzone
boundaries and the scope of authority
under zone procedures in terms of both
products and capacity within Subzone
99D for the manufacture of
pharmaceutical products at the
AstraZeneca pharmaceutical
manufacturing plants located in Newark
and Wilmington, Delaware, as described
E:\FR\FM\14JNN1.SGM
14JNN1
34304
Federal Register / Vol. 71, No. 114 / Wednesday, June 14, 2006 / Notices
in the application and the Federal
Register notice, subject to the FTZ Act
and the Board’s regulations, including
Section 400.28.
Signed at Washington, DC, this
May 2006.
31st
day of
David M. Spooner,
Assistant Secretary of Commerce for Import
Administration, Alternate Chairman Foreign–
Trade Zones Board.
Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–9304 Filed 6–13–06; 8:45 am]
Signed at Washington, DC, this 26th day of
May 2006.
Foreign–Trade Zones Board.
Carlos M. Gutierrez,
Secretary of Commerce, Chairman and
Executive Officer.
Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–9305 Filed 6–13–06; 8:45 am]
BILLING CODE 3510–DS–S
U.S. DEPARTMENT OF COMMERCE
BILLING CODE 3510–DS–S
Foreign–Trade Zones Board
Signed at Washington, DC, this 26th day of
May 2006.
U.S. DEPARTMENT OF COMMERCE
[Order No. 1452]
Foreign–Trade Zones Board
Grant of Authority for Subzone Status,
JBE, Inc. (Automotive Parts),
Hartsville, South Carolina
[Order No. 1444]
Grant of Authority, Establishment of a
Foreign–Trade Zone, Lawrence
County, Ohio
rwilkins on PROD1PC63 with NOTICES
Pursuant to its authority under the
Foreign–Trade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the Foreign–
Trade Zones Board adopts the following
Order:
Whereas, the Foreign–Trade Zones
Act provides for ’’ * * * the
establishment * * * of foreign–trade
zones in ports of entry of the United
States, to expedite and encourage
foreign commerce, and for other
purposes,’’ and authorizes the Foreign–
Trade Zones Board to grant to qualified
corporations the privilege of
establishing foreign–trade zones in or
adjacent to U.S. Customs ports of entry;
Whereas, the Lawrence County Port
Authority (the Grantee), an Ohio public
corporation, has made application to the
Board (FTZ Docket 52–2005, filed 10/
20/05), requesting the establishment of
a foreign–trade zone at a site in
Lawrence County, Ohio, adjacent to the
Charleston Customs port of entry;
Whereas, notice inviting public
comment has been given in the Federal
Register (70 FR 61786, 10/26/05); and,
Whereas, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations are satisfied, and
that approval of the application is in the
public interest;
Now, therefore, the Board hereby
grants to the Grantee the privilege of
establishing a foreign–trade zone,
designated on the records of the Board
as Foreign–Trade Zone No. 270, at the
site described in the application, and
subject to the Act and the Board’s
regulations, including Section 400.28.
VerDate Aug<31>2005
20:36 Jun 13, 2006
Jkt 208001
Pursuant to its authority under the
Foreign–Trade Zones Act, of June 18, 1934,
as amended (19 U.S.C. 81a–81u), the
Foreign–Trade Zones Board (the Board)
adopts the following Order:
Whereas, the Foreign–Trade Zones
Act provides for ’’ * * * the
establishment * * * of foreign–trade
zones in ports of entry of the United
States, to expedite and encourage
foreign commerce, and for other
purposes,’’ and authorizes the Foreign–
Trade Zones Board to grant to qualified
corporations the privilege of
establishing foreign–trade zones in or
adjacent to U.S. Customs and Border
Protection ports of entry;
Whereas, the Board’s regulations (15
CFR Part 400) provide for the
establishment of special–purpose
subzones when existing zone facilities
cannot serve the specific use involved,
and when the activity results in a
significant public benefit and is in the
public interest;
Whereas, the Columbia Metropolitan
Airport, grantee of Foreign–Trade Zone
127, has made application to the Board
for authority to establish a special–
purpose subzone at the automotive parts
distribution and assembly facility of
JBE, Inc., located in Hartsville, South
Carolina (FTZ Docket 55–2005, filed 11/
2/05);
Whereas, notice inviting public
comment was given in the Federal
Register (70 FR 69937, 11/18/05); and,
Whereas, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations would be satisfied,
and that approval of the application
would be in the public interest if
approval is subject to the condition
listed below;
PO 00000
Frm 00005
Fmt 4703
Sfmt 4703
Now, therefore, the Board hereby
grants authority for subzone status for
activity related to the distribution and
assembly of automotive parts at the
facility of JBE, Inc., located in
Hartsville, South Carolina (Subzone
127B), as described in the application
and Federal Register notice, and subject
to the FTZ Act and the Board’s
regulations, including Section 400.28,
and subject to the following condition:
• JBE, Inc., shall notify the Board’s
Executive Secretary, as indicated in the
application, prior to the start of any
manufacturing or assembly activity
involving foreign status inputs.
David M. Spooner,
Assistant Secretary of Commerce for Import
Administration.
Alternate Chairman Foreign–Trade Zones
Board.
Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–9306 Filed 6–13–06; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–831]
Fresh Garlic from the People’s
Republic of China: Extension of Time
Limits for the Preliminary Results of
the 11th Administrative Review and
New Shipper Reviews
Import Administration,
International Trade Administration,
Department of Commerce.
EFFECTIVE DATE: June 14, 2006.
FOR FURTHER INFORMATION CONTACT:
Irene Gorelik, AD/CVD Operations,
Office 9, Import Administration,
International Trade Administration,
U.S. Department of Commerce, 14th
Street and Constitution Avenue, NW,
Washington DC 20230; telephone: (202)
482–6905.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On December 22, 2005, the
Department published a notice of
initiation of a review of fresh garlic from
the People’s Republic of China (‘‘PRC’’),
covering the period November 1, 2004,
through October 31, 2005. See Initiation
of Antidumping and Countervailing
Duty Administrative Reviews and
Requests for Revocation in Part, 70 FR
76024 (December 22, 2005). On
December 28, 2005, the Department
published a notice of initiation of new
E:\FR\FM\14JNN1.SGM
14JNN1
Agencies
[Federal Register Volume 71, Number 114 (Wednesday, June 14, 2006)]
[Notices]
[Pages 34303-34304]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9304]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Order No. 1455]
Approval For Expansion Of Subzone 99D, AstraZeneca
Pharmaceuticals LP Plant, (Pharmaceutical Products), Newark and
Wilmington, Delaware
Pursuant to its authority under the Foreign-Trade Zones Act of
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade
Zones Board (the Board) adopts the following Order:
Whereas, the Delaware Economic Development Office, grantee of FTZ
99, has requested authority on behalf of AstraZeneca Pharmaceuticals LP
(AstraZeneca), to expand the subzone boundaries and to expand the scope
of manufacturing authority under zone procedures in terms of both
products and capacity at Subzone 99D at the AstraZeneca pharmaceuticals
manufacturing plant in Newark, Delaware (FTZ Docket 22-2005, filed 5/
17/2005); and,
Whereas, notice inviting public comment has been given in the
Federal Register (70 FR 30079, 5/25/05);
Whereas, the Board adopts the findings and recommendation of the
examiner's report, and finds that the requirements of the FTZ Act and
Board's regulations are satisfied, and that approval of the application
is in the public interest;
Now, therefore, the Board hereby approves the expansion of the
subzone boundaries and the scope of authority under zone procedures in
terms of both products and capacity within Subzone 99D for the
manufacture of pharmaceutical products at the AstraZeneca
pharmaceutical manufacturing plants located in Newark and Wilmington,
Delaware, as described
[[Page 34304]]
in the application and the Federal Register notice, subject to the FTZ
Act and the Board's regulations, including Section 400.28.
Signed at Washington, DC, this 31\st\ day of May 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import Administration, Alternate
Chairman Foreign-Trade Zones Board.
Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6-9304 Filed 6-13-06; 8:45 am]
BILLING CODE 3510-DS-S